Percentage Changes According to Pathological Findings of Sentinel Lymph Node in Early and Early–like progressive Gastric Cancer
DOI:
https://doi.org/10.46966/msjar.v6i4.322Abstract
Background: Gastric cancer is considered to take the first place in incidence among visceral cancers in our country. We have studied to solve the problems to contribute gastric surgery practice and the studying aim is to identify appearance of SLN, order of incidence and average amount.,We selected 121 early and early-like progressive gastric cancer patients (Male: Female =2.7:1) who had undergone operations within last 10 years at Tumor Research Station of Medical Research Institute.We gradually injected 1ml of micro-activated charcoal saline liquid centering the gastric cancer lesion throughout four cardinal directions into submucous and subserous tissue of the patients who had been diagnosed as early gastric cancer and confirmed to have the indication for an operation so that we could excise the colored SLNs after 15-20 minutes with the lesion. We measured the size of the lesion pathomorphologically, confirmed the macroscopic findings, took the tissue specimen, stained them with H-E under the general sampling principles and finally observed histopatholgical findings microscopically to confirm its histological findings, differentiation and microscopic depth. For the test of significance with the appearance of SLN according to pathological indications, we performed χ2-test and with the average amount of SLN, we performed t-test. Conclusion: The percentage changes of SLN presence according to pathological indications of early and early-like progressive cancer are like the following. The average amount of SLN was 1.41, The order of SLN appearances was like this., No5 lymph node (suprapyloric lymph node)-24.0%,, No6 lymph node (subpyloric lymph node)-18.2%, No1 lymph node (pyloric lymph node)-11.6%.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Hyon Chol Jo, Hak song Jo, Yong Ho Kim, Yong Gun Yun, Un-Hyang Ho

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















